Abstract:Epidermal growth factor (EGF) signaling and Hedgehog (HH) signaling are both involved in prostate cancer (PCa) progression, yet the mechanisms through which these two pathways are synergistically linked require elucidation. In the present study, we aimed to ascertain how EGF and the HH signaling transcription factor GLI-1 are linked in prostate cancer invasiveness. ARCaP human prostate cancer cells, which included ARCaP(E) and ARCaP(M) cells, were used as a model in the present study. The expression of EGF receptor (EGFR) and the HH signaling transcriptional factor GLI-1 were detected in ARCaP(E) cells by immunofluorescence, and the ARCaP(E) cells were treated with human recombinant EGF protein (hrEGF) for 4 consecutive days in vitro. Transwell invasion assays were performed in the ARCaP(E) cells following treatment with DMSO (vehicle control), hrEGF, GATN61 (GLI-1-specific inhibitor), hrEGF plus GANT61 and in the ARCaP(M) cells. The expression of phosphorylated extracellular signal regulated kinase (p-ERK), total ERK and GLI-1 was detected by western blotting in ARCaP(E) cells at different time-points following treatment with hrEGF. The expression of EGFR and GLI-1 was detected in ARCaP(E) cells, which exhibited a cobblestone-like morphology, while after treatment with hrEGF, the cell morphology was altered to a spindle-shaped mesenchymal cell morphology. Transwell invasion assays demonstrated that hrEGF dramatically enhanced the invasive capability of the ARCaP(E) cells (P<0.05). Additionally, western blot assay demonstrated that the expression levels of p-ERK and GLI-1 in ARCaP(E) cells increased in a time-dependent manner after treatment with hrEGF (P<0.05); however, the expression levels of total ERK in the cells remained relatively unchanged. It also demonstrated that the GLI-1 inhibitor GANT61 could reverse the enhanced invasive effect induced by EGF in ARCaP(E) cells (P<0.05). Our preliminary in vitro study showed that EGF signaling may increase the invasive capability of ARCaP(E) human prostate cancer cells via upregulation of p-ERK and the HH signaling transcriptional factor GLI-1. Additionally, this enhanced cell invasive effect was reversed by a GLI-1-specific inhibitor in vitro. Consequently, it indicates that both EGF and HH signaling are synergistically involved in the progression of human prostate cancer ARCaP cells, and GLI-1 may be one of the important effectors, which is activated by EGF downstream signaling, to promote the invasiveness of ARCaP(E) prostate cancer cells.

Induction of IGF-1R expression by EGR-1 facilitates the growth of prostate cancer cells.

EGR1 Promotes Proliferation in Prostatic Hyperplasia Epithelial BPH-1 Cells

E2F1 Renders Prostate Cancer Cell Resistant to ICAM-1 Mediated Antitumor Immunity by NF-κB Modulation.

E2f1 Induces Tumor Cell Survival Via Nuclear Factor-Kappa B-Dependent Induction of Egr1 Transcription in Prostate Cancer Cells

Targeted Knockdown of EGR-1 Inhibits IL-8 Production and IL-8-mediated Invasion of Prostate Cancer Cells Through Suppressing EGR-1/NF-κB Synergy

EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis

Role of GLI-1 in Epidermal Growth Factor-Induced Invasiveness of ARCaP(E) Prostate Cancer Cells

[Epidermal Growth Factor Up-Regulates the Mrna Expression of Endothelin-1 and Its Receptors in Prostate Cancer PC-3 Cell Lines].

The Role of the Transcription Factor EGR1 in Cancer

Androgen Deprivation Therapy Induces Androgen Receptor-Dependent Upregulation Of Egr1 In Prostate Cancers

Expression of Insulin-Like Growth Factor-I Signaling Pathway in Prostatic Cancer and Its Significance

Transcription Factor EGR-1 Suppresses the Growth and Transformation of Human HT-1080 Fibrosarcoma Cells by Induction of Transforming Growth Factor Beta 1.

Emerging Role of IGF-1 in Prostate Cancer: A Promising Biomarker and Therapeutic Target

Inhibition of EGR1 Inhibits Glioma Proliferation by Targeting CCND1 Promoter

[GLI-1 is Involved in EGF-regulated Enhancement of the Invasiveness of Prostate Cancer ARCaP(E) Cells in Vitro].

Early Growth Response-1 Suppresses Human Fibrosarcoma Cell Invasion and Angiogenesis.

ERG activates a stem-like proliferation-differentiation program in prostate epithelial cells with mixed basal-luminal identity

IGFs regulate cancer cell immune evasion in prostate cancer

The reciprocal regulation of gamma-synuclein and IGF-I receptor expression creates a circuit that modulates IGF-I signaling.

Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth

Estrogen Receptor Alpha is Essential for the Proliferation of Prostatic Smooth Muscle Cells Stimulated by 17β‐estradiol and Insulin‐like Growth Factor 1